Kangkai Xia

404 total citations
13 papers, 297 citations indexed

About

Kangkai Xia is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kangkai Xia has authored 13 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kangkai Xia's work include Ubiquitin and proteasome pathways (6 papers), Protease and Inhibitor Mechanisms (3 papers) and Photodynamic Therapy Research Studies (2 papers). Kangkai Xia is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Protease and Inhibitor Mechanisms (3 papers) and Photodynamic Therapy Research Studies (2 papers). Kangkai Xia collaborates with scholars based in China and United States. Kangkai Xia's co-authors include Huijian Wu, Shujing Li, Yanan Li, Bowen Li, Xiahui Li, Yuxi Yang, Yangyang Yang, Xiao‐Yan Bai, Zhaowei Xu and Miao Wang and has published in prestigious journals such as Biomacromolecules, Cancer Letters and Cell Death and Disease.

In The Last Decade

Kangkai Xia

13 papers receiving 296 citations

Peers

Countries citing papers authored by Kangkai Xia

Since Specialization

Citations

This map shows the geographic impact of Kangkai Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangkai Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangkai Xia more than expected).

Fields of papers citing papers by Kangkai Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangkai Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangkai Xia. The network helps show where Kangkai Xia may publish in the future.

Co-authorship network of co-authors of Kangkai Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Kangkai Xia. A scholar is included among the top collaborators of Kangkai Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kangkai Xia. Kangkai Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer 2023 ·Cell Death and Disease ·Kangkai Xia, Shujing Li, Yuxi Yang, Xiaoxia Shi, (unknown), Linlin Lv, (unknown), (unknown), (unknown), Huijian Wu	11
2	TIMELESS inhibits breast cancer cell invasion and metastasis by down-regulating the expression of MMP9 2021 ·Cancer Cell International ·Bowen Li, (unknown), Yanan Li, Kangkai Xia, (unknown), (unknown), (unknown), Shujing Li, Huijian Wu	6
3	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1 2021 ·npj Precision Oncology ·Xiahui Li, Shujing Li, Bowen Li, Yanan Li, (unknown), Kangkai Xia, Yuxi Yang, Bashir Ahmad, Huijian Wu	18
4	FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα 2021 ·Cancer Letters ·Yangyang Yang, Shujing Li, Bowen Li, Yanan Li, Kangkai Xia, (unknown), Yuxi Yang, Bashir Ahmad, (unknown), Huijian Wu	18
5	DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9 2021 ·Cell Death Discovery ·(unknown), Yanan Li, (unknown), Yuxi Yang, Linlin Lv, Bowen Li, Kangkai Xia, Shujing Li, Huijian Wu	20
6	Codelivery of High-Molecular-Weight Poly-porphyrins and HIF-1α Inhibitors for In Vivo Synergistic Anticancer Therapy 2021 ·Biomacromolecules ·(unknown), Kangkai Xia, (unknown), Wangze Song, Yubin Zheng, Guishan Xiao, Huijian Wu, Nan Zheng	10
7	Linear and high-molecular-weight poly-porphyrins for efficient photodynamic therapy 2021 ·Biomaterials Science ·Nan Zheng, Xiahui Li, (unknown), Kangkai Xia, (unknown), Huijian Wu, Wangze Song	17
8	SUMOylation of MCL1 protein enhances its stability by regulating the ubiquitin-proteasome pathway 2020 ·Cellular Signalling ·Shujing Li, Jin Wang, (unknown), (unknown), Bowen Li, Yanan Li, Kangkai Xia, Yuxi Yang, Bashir Ahmad, Miao Wang, Huijian Wu	16
9	Circadian protein BMAL1 promotes breast cancer cell invasion and metastasis by up-regulating matrix metalloproteinase9 expression 2019 ·Cancer Cell International ·Jian Wang, Shujing Li, Xiahui Li, Bowen Li, Yanan Li, Kangkai Xia, Yuxi Yang, (unknown), Miao Wang, Huijian Wu	69
10	Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer 2019 ·Disease Markers ·Xiao Jiang, Xiao‐Yan Bai, Bowen Li, Yanan Li, Kangkai Xia, Miao Wang, Shujing Li, Huijian Wu	24
11	α-catenin SUMOylation increases IκBα stability and inhibits breast cancer progression 2018 ·Oncogenesis ·Huan Chen, Zhaowei Xu, Xiahui Li, Yangyang Yang, Bowen Li, Yanan Li, Kangkai Xia, Jian Wang, Shujing Li, Miao Wang, Huijian Wu	8
12	Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1 2018 ·Cell Death and Disease ·Zhaowei Xu, Yangyang Yang, Bowen Li, Yanan Li, Kangkai Xia, Yuxi Yang, Xiahui Li, Miao Wang, Shujing Li, Huijian Wu	20
13	Krüppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion 2017 ·Cancer Letters ·Xiao‐Yan Bai, Shujing Li, Miao Wang, Xiahui Li, Yangyang Yang, Zhaowei Xu, Bowen Li, Yanan Li, Kangkai Xia, Huan Chen, Huijian Wu	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact